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Abstract
Several large DNA viruses encode Bcl-2 protein homologues involved in the regulation of the cellular apoptosis cascade. This regulation often
involves the interaction of these viral proteins with diverse cellular Bcl-2 family members. We have identified the specific interactions of A179L,
an African swine fever virus (ASFV) Bcl-2 homologue, with the active forms of the porcine BH3-only Bid protein (truncated Bid p13 and p15).
Transient expression of ASFVA179L gene in Vero cells prevented apoptosis induced by these active forms of Bid protein. Interestingly, A179L
protein was able to interact, also with the main core Bcl-2 proapoptotic proteins Bax and Bak, and with several BH3-only proteins with selective
binding restrictions for full length Bid and Noxa. These results suggest a fine regulation for A179L action in the suppression of apoptosis in
infected cells which is essential for efficient virus replication.
© 2008 Elsevier Inc.Open access under CC BY license.Keywords: Apoptosis; Bid; Virus–cell interaction; African swine fever virusIntroduction
Some of the best studied cellular apoptosis regulators belong
to the Bcl-2 family, which include both proapoptotic and
antiapoptotic effectors (Korsmeyer, 1995; White, 1996).
Members of Bcl-2 family have common conserved regions,
designated Bcl-2 homology regions 1, 2, 3 and 4 (BH1, BH2,
BH3 and BH4). Bcl-2 protein is the prototypical member that
negatively regulates apoptosis and contains all the Bcl-2
domains. This protein preserves mitochondrial integrity by
interacting with Bcl-2 family proapoptotic members (Petros
et al., 2004). Apoptosis inducer members include BH3-only
proteins, which are cellular damage sensors that initiate rapidly
the death process, and Bax-like proteins that act downstream ofAbbreviations: vBcl-2, viral Bcl-2; cBcl-2, cellular Bcl-2; ORF, open
reading frame; HA, hemagglutinin tag; Bid, BH3 interacting domain death
agonist; tBid, truncated Bid; ASFV, African swine fever virus.
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Open access under CC BY license.BH3-only proteins to permeabilise the mitochondrial outer
membrane (Bouillet and Strasser, 2002).
The apoptosis cascade may be initiated by pathogenic agents
such as viruses and is considered as part of the cellular
defensive mechanism. Viruses have adapted numerous ways of
circumventing this host defensive response, including regula-
tion of endogenous host death receptors and ligands, expression
of caspase activation inhibitors, regulation of host Bcl-2
proteins, and expression of viral homologues of Bcl-2 (vBcl-
2s) (Benedict et al., 2002; Polster et al., 2004).These viral genes
encoding proteins with amino acid sequence similarity to
cellular Bcl-2 apoptosis inhibitors have been identified in
several viral models including Epstein–Barr virus (EBV)
(Bellows et al., 2002; Henderson et al., 1993), human herpes
virus 8 (HHV8) (Cheng et al., 1997) and African swine fever
virus (ASFV) (Afonso et al., 1996) between others. The role of
these vBcl-2s in diverse aspects of the viral cell-cycle and their
mechanism of action has been gradually emerging (Everett and
McFadden, 1999; Hardwick and Bellows, 2003). VBcl-2s
mediate inhibition of apoptosis in infected cells and prevent
premature death of the host cell which would impair virus
replication and might have also a role in the development of
persistent infection (Cuconati and White, 2002).
Fig. 1. ASFVA179L interaction with porcine tBid-p13 in mammalian cells by
affinity chromatography and confocal microscopy. (a) Total cell lysates from
single transfected cells with either tBid-p13–myc or A179L–HAwere blotted for
anti-myc or anti-HA (left panel). Interaction of A179L with tBid-p13 was
confirmed by immunoprecipitation of HA-tagged A179L and myc-tagged tBid-
p13, fromVero cells transfected with the corresponding expression constructs. The
immunoprecipitates were analyzed by SDS-PAGE and subjected to immunoblot-
ting with antibodies against myc or HA. Lane 1, immunoprecipitation with a mAb
against HA. Lane 2, immunoprecipitation with normal mouse serum (right panel).
(b) Vero cells were transiently transfected with pCMVA179L–HA and
pCMVtBid-p13–myc plasmids. Colocalization of A179L and tBid-p13 was
assayed by confocal microscopy. A179L was detected with anti-HA-Alexa 594
(red) and tBid-p13 with anti-myc-FITC (green). Nuclei were stained with Hoechst
33258 (blue). Colocalization areas are depicted in yellow.
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large DNA virus that induces an acute disease of swine in
which apoptosis plays a central role in pathogenesis. Virus
infection induces apoptosis in target and immune defence
cells (Oura et al., 1998; Ramiro-Ibanez et al., 1996). This
programmed cell death induction in the target cell has been
recently tracked in vivo in living cells as infection progresses
and the execution phase of apoptosis becomes evident at late
infection times (Hernaez et al., 2006). In fact, ASFV encodes
for various apoptosis inhibitor genes, one of these sharing
high sequence similarity to cellular Bcl-2, the ASFV A179L
gene (Revilla et al., 1997; Yanez et al., 1995). This gene
encodes for a 21 kDa protein which is expressed at early and
late times after infection and is essential for virus replication
throughout the infection cycle (Brun et al., 1996; Neilan et al.,
1993). A179L is highly conserved in most ASFV isolates,
both in pathogenic and cell-cultured adapted isolates. In
comparison to other viral Bcl-2s, its sequence is very similar
to the cellular protein containing all the characteristic Bcl-2
homology domains (BH1, BH2, BH3 and BH4), but lacking
the transmembrane region (Afonso et al., 1996). A179L is
involved in the suppression of apoptosis in ASFV infected
cells (Brun et al., 1996) and prolongs host cell survival until
the replication of the large viral genome is completed. Pro-
longed cell survival could be relevant facilitating a persistent
infection (Afonso et al., 1996; Brun et al., 1996). Moreover,
given the fact that immune defence entails cytotoxic T lym-
phocytes attack against infected cells by TNFα, FasL or
TRAIL, A179L could play a role in the infected cell escape to
premature death due to cytokine signalling. Mutations in the
BH1 domain of A179L abrogate its death-repressor activity
(Revilla et al., 1997). Interestingly, this protein is functional and
prevents virus induced apoptosis not only in mammalian cells
but also in insect cells (Brun et al., 1998), indicating a very low
degree of species-specificity, as would be required of a viral
protein that should exert its function in both, mammals and the
arthropod vector (White, 1996). The ASFV arthropod vectors
are ticks of the Ornithodorus genus (Plowright et al., 1969).
However, the precise mechanism of action of A179L
remains undefined. Some evidences suggest that most vBcl-2s
might target the core cellular proapoptotic machinery for
inhibition (Bellows et al., 2002; Nava et al., 1997), but also
redundant actions on specific, short BH3 proapoptotic members
have been described (Boyd et al., 1995; Han et al., 1996b)
probably directed to secure apoptosis inhibition in the infected
cell.
The aim of this work was to characterize the biochemical
mechanisms by which the A179L protein suppresses apoptosis.
Active forms of Bid protein from Sus scrofawere first identified
as A179L interacting proteins. A179L blocked Bid-induced
apoptosis when transfected in Vero cells, pointing out that
A179L action may take place downstream of caspase 8 or
granzyme B cleavage. In this work, we have shown that A179L
protein interacted specifically with both BH3-only proapoptotic
proteins and the core cellular proapoptotic machinery suggest-
ing a central role for this protein in the inhibition of apoptosis
induced by a wide variety of stimuli.Results
Interaction of ASFV A179L protein with p13 truncated Bid
protein
Although previous results demonstrated that ASVF A179L
protects cells from programmed cell death, the molecular
mechanisms supporting this biological effect remain to be
determined. To elucidate the role of the virus Bcl-2 homologue,
the yeast two hybrid system was used to screen a porcine
macrophage cDNA library with full-length A179L as bait,
searching for cellular interacting proteins. Two yeast clones
were identified to induce the expression of the three reporter
genes (HIS3, LEU2, TRIP1), as indicated by growth on SD
medium and blue staining in the presence of X-α-Gal. These
two cDNA clones were characterized by nucleotide sequence
analysis. One of these clones was not included in these studies
because the sequence revealed no significant homology to any
known gene or translated product at the NCBI data base.
Another cDNA clone was found to encode a porcine protein
with high percentage homology (65%) to tBid-p13 protein from
Homo sapiens. TBid-p13 protein corresponds to the carboxy-
terminal fragment of Bid protein, named truncated Bid (tBid).
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receptors and results from post-transductional cleavage of full
length Bid by caspase 8 or granzyme B (Li et al., 1998; Luo
et al., 1998). The resulting protein of 13 kDa has been found to
be one of the active forms of Bid protein inducing apoptosis
(Gross et al., 1999a,b; Stoka et al., 2001).Fig. 2. Complete sequence of porcine Bid protein. (a) Full length Bid open reading fra
domain (bold) and putative cleavage sites (underlined) are indicated. (b) Schemati
domains. (c) Homology to other annotated Bid proteins. The identity/similarity valu
Percentages of similarity for BH3 domain were calculated including in each BH3 dom
rat Bid 87–99, avian Bid 87–99 and porcine Bid 83–95. For full open reading frame (O
from the start codon to the stop codon.To further confirm the interaction of tBid-p13 and ASVF
A179L we tested the association of both proteins by
immunoprecipitation. Protein extracts from Vero cells expres-
sing A179L–HA or tBid-p13–myc protein were incubated with
protein A-sepharose, previously conjugated with anti-HA
antibody or with an irrelevant rabbit serum. After extensiveme (ORF) cDNA clone and its predicted amino acid sequence. A conserved BH3
c structure of porcine Bid isoforms, pointing out BH3 and protease cleavage
es (%) were obtained from ClustalW program (http://www.ebi.ac.uk/clustalw/).
ain the following amino acid residues: Human Bid aa 86–98, mouse Bid 85–97,
RF) comparation, the full-length protein for each species analyzed was included
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with anti-myc or anti-HA antibodies (Fig. 1a). Results showed
that tBid-p13–myc was coimmunoprecipitated with A179L–
HA by the anti-HA antibody, confirming the interaction
between these two proteins (Fig. 1a, lane 1). As expected,
tBid-p13–myc was not immunoprecipitated by the irrelevant
rabbit serum (Fig. 1a, lane 2).
To gain further insight into the interaction between A179L
and p13 truncated form of Bid protein, confocal microscopy
assays were also performed in Vero cells transiently expressing
both proteins. In agreement with the results found with the two-
hybrid assay, we found colocalization of both proteins, A179L
and p13 truncated form of Bid (Fig. 1b). The subcellular
localization of porcine tBid, diffusely distributed throughout the
cytoplasm, was similar to that of other reported Bid proteins
(Wang et al., 1996). A179L stained diffusely the cytoplasm with
a significant proportion accumulating in the perinuclear space.
Colocalization of both proteins, A179L and tBid-p13, was
found mainly in the perinuclear region as it is shown in the
overlay (colocalization percentage over 72%). The above
results indicate an interaction between ASFV A179L and
porcine truncated Bid protein not only in vitro but also in vivo.
Isolation and sequence analysis of cDNA encoding porcine Bid
On the basis of the information from NCBI data base, where
the A179L interacting sequence showed a high degree of
homology with one of the truncated forms of human Bid
protein, a RACE-PCR was performed to obtain the complete
sequence for porcine Bid protein. The full length sequence
generated of porcine Bid gene was deposited at GenBank under
accession no DQ087226.
This sequence predicts an open reading frame of 579
nucleotides encoding for a protein of 192 amino acids. The
protein contains a BH3 domain from amino acid 83 to amino
acid 95. Moreover, similarly to the human Bid sequence, the
analysis of the porcine sequence indicated the presence of
two potential cleavage sites present in the full length protein
(Fig. 2a). The primary site (LQTDG), at 54–57 amino acids, is
the putative caspase 8 and 1 cleavage sites which generate a
15 kDa truncated form of Bid protein (tBid-p15 protein). The
secondary site (AETD) at residues 69–72, would be recognized
by both caspase 8 and granzyme B, generating tBid-p13 protein.
A third cleavage site generating tBid-p11 protein, described in
H. sapiens as an inactive form of Bid (Gross et al., 1999a,b),
was not found in the porcine Bid sequence however (Fig. 2b).
A comparison between the deduced amino acid sequences of
porcine Bid with those from other organisms was performed
using the computer analysis tool ClustalW. The porcine Bid
sequence exhibited high identity with every annotated sequenceFig. 3. Proapoptotic activity of truncated Bid isoforms in Vero cells. (a) Vero cells
pCMVtBid-p13–myc or pCMVtBid-p15–myc. Full length and truncated forms of B
33258 (blue). Cells transfected with active Bid forms showed nuclear features charact
pattern. In contrast, full length Bid transfection did not result in altered nuclear mo
activation of caspase 3. (c) Vero cells expressing Bid truncated forms presented irregu
dye (CMXRos, orange). The finely reticular mitochondrial pattern is evident in nonfrom mammalian origin Bid proteins (Fig. 2c): H. sapiens
(64%), Mus musculus (59%) and Rattus novergicus (59%). In
contrast, porcine Bid was less closely related to avian Bid
protein (Gallus gallus), with an identity of 34%. Alignment of
Bid amino acid sequences indicates that the BH3 domain is
highly conserved between species, sharing 75–60% identity
(Fig. 2c). Cleavage sites were also conserved, particularly,
primary cleavage site (LQTD) which was identical in all five
species examined (100%). Secondary cleavage site (AETD)
yielded lower identity percentage (50%) between the porcine
Bid site and the homologue mammalian sequences.
Apoptosis induction by porcine Bid truncated isoforms in Vero
cells
On the basis of its homology with human and murine Bid
proteins, we predicted that porcine Bid protein would also
function as a proapoptotic protein. To investigate the proapop-
totic activity of porcine Bid protein, as well as its truncated
forms activities, we transfected Vero cells with either
pCMVBid–myc, pCMVtBid-p13–myc, pCMVtBid-p15–myc
or empty pCMV–HA (negative control) constructs and
examined by immunofluorescence microscopy.
As described in other species, Vero cells expressing full
length porcine Bid did not show evident apoptosis features or
morphological changes up to 24 h after transfection. In contrast,
characteristic nuclear features of apoptosis were found in those
cells expressing tBid-p13 and tBid-p15. Condensation and
fragmentation of chromatin, leading to typically small or
shrunken nuclei were found in cells expressing truncated forms
of Bid protein, whereas cells transfected with control vector and
full length Bid exhibited intact round-shaped nuclei with diffuse
bright blue fluorescence with Hoechst 33258 staining (Fig. 3a).
In the same way, cells transiently expressing truncated forms
of Bid, but not complete Bid, showed activation of caspase 3
(Fig. 3b). In order to further characterize apoptosis induced by
the active forms of Bid protein, a potential-sensitive dye
(CMXRos) was used to determine mitochondrial changes.
Mitochondria stained finely distributed along the cytoplasm in
healthy non-transfected cells. Nevertheless, cells transfected
with the active forms of Bid proteins changed dramatically this
distribution, presenting accumulation and irregular clumping
(Fig. 3c). In these transfected cells, either tBid-p13 or tBid-p15,
was found localizing with mitochondria. These morphological
changes were easily observed in 96 and 92% of the cells
transiently expressing tBid-p13–myc and tBid-p15–myc,
respectively, from a total of 50 transfected cells examined.
Jointly, these results showed the proapoptotic activity of
truncated porcine Bid proteins rapidly inducing apoptosis after
transient transfection. In addition, the absence of proapoptoticwere tranfected with either pCMV–myc (negative control), pCMVBid–myc,
id, were detected using anti-myc-FITC (green). DNAwas stained with Hoechst
eristic of apoptosis: nuclear size reduction, condensation and irregular chromatin
rphology. (b) Expression of truncated forms of Bid in transfected cells induced
lar mitochondrial clumping using a mitochondrial membrane potential-sensitive
-transfected cells (arrows).
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Table 1
Interaction of ASVF proteins A179L, p30, p54 and MyD with mammalian Bax,
Bak and BH3 only proteins, as judged by yeast two hybrid assays
A179L p54 p30 MyD
Bid (Ss) − − − −
tBid-p15 (Ss) + − − −
tBid-p13 (Ss) + − − −
Bid (Mm) − − − −
Bad (Mm) + − − −
Bmf (Mm) + − − −
Noxa (Hs) − − − −
Puma (Hs) + − − −
DP5 (Mm) + − − −
Bik (Hs) + − − −
Biklk (Mm) + − − −
Bim S (Mm) + − − −
Bim L (Mm) + − − −
Bim EL (Mm) + − − −
Bax (Hs) + − − −
Bak (Hs) + − − −
Plasmids expressing viral proteins A179L, p30, p54 or MyD fused to GAL4
DNA-binding domain were cotransfected with plasmids expressing each Bcl-2
proapoptotic members fused to the GAL4 transcriptional activation domain.
Protein-protein interaction (+) resulted in growth of yeast in absence of leucine,
trytophan and histidine and blue staining in presence of X-Gal. Interaction was
negative (−) with full length Bid, Noxa and irrelevant viral proteins included as
controls. Ss: Sus scrofa, Mm: Mus musculus; Hs, Homo sapiens.
Fig. 4. Proapoptotic activity in Vero cells expressing simultaneously ASVF
A179L and truncated Bid proteins. Plasmids expressing pCMVtBid-p13–myc
or pCMVtBid-p15–myc were cotransfected alternatively in Vero cells together
with pCMVA179L–HA. An antibody against the myc epitope tag FITC
conjugated (green) and anti-HA antibody conjugated with Alexa 594 (red) were
used to detect truncated Bid and A179L proteins, respectively and Hoechst
33258 DNA dye stained nuclei in blue. Single transfected cells with truncated
Bid underwent typical apoptosis changes with a marked size reduction (arrows)
while cotransfected cells conserved normal morphology.
566 I. Galindo et al. / Virology 375 (2008) 561–572activity of full length porcine Bid protein is in agreement with
the notion that only caspase 8 or granzyme B post-transduc-
tional processing render this protein active.
Inhibition of proapoptotic activity of truncated forms of Bid by
specific interaction with A179L
Although sequence analysis and functional experiments
showed that there are at least three isoforms of porcine Bid
protein, only tBid-p13 protein, was at first identified as an
ASFV A179L interacting protein when a yeast two hybrid
screening was conducted using a porcine macrophage library.
To determine if A179L was also able to interact with others
forms of porcine Bid protein (full length Bid and tBid-p15), we
performed a series of direct yeast two hybrid assays. Y190 yeast
strain was cotransformed with pGBT9–A179L vector and
pATC2 vector containing Bid, tBid-p13 or tBid-p15. The results
(Table 1) indicated that A179L selectively interacts with active
forms of Bid protein, tBid-p13 and tBid-p15, and failed to
associate with full length Bid, the inactive form of Bid protein.
Once the interaction between A179L protein and the active
forms of porcine Bid protein was found, we investigated the
functional role of these interactions and whether A179L binding
to truncated forms of Bid could interfere with the death signal
mediated by these proteins. We first tested proapoptotic activity
mediated by active Bid isoforms alone. For this purpose, Vero
cells were cotransfected with pCMV–A179L–HA and
pCMVtBid-p13–myc or pCMVtBid-p15–myc and were then
analyzed by laser confocal microscopy. As it was shown above
(Fig. 3), 24 h post-transfection, expression of tBid proteins
induced apoptosis features. In contrast, every cell transiently
expressing A179L and either tBid-p13 or tBid-p15 did not showapoptosis features; that is, double positive cells exhibited
healthy cellular morphology (Fig. 4). DNA pattern evaluation in
those single transfected cells expressing truncated Bid proteins
revealed nuclei condensation and chromatin fragmentation
(Fig. 4, indicated by arrows). Moreover, these cells exhibited
rounding and nuclear size reduction. Jointly, these results
suggest that A179L is able to impact on apoptotic pathway
mediated by the BH3-only protein Bid, which is a central actor
in the death receptor apoptosis pathway, protecting the host cell
against programmed cell death.
Interaction of A179L with Bcl-2 proapoptotic proteins
Many of the viral Bcl-2 homologues have been shown to
inhibit apoptosis induced by a variety of cell death stimuli
(Cuconati and White, 2002). Nevertheless, different death
stimuli seem to activate different BH3-only effectors. To further
investigate which pathways were inhibited by A179L, we tested
if this protein was able to interact with other proapoptotic Bcl-2
family proteins (Table 1). Several mammalian BH3-only pro-
teins, including murine Bid were cloned into pATC2 vector to
be used in a yeast two-hybrid assay. Three isoforms of Bim
(Bim S, Bim L and Bim EL) were analyzed, since differences in
the proapoptotic potential activity of these isoforms have been
previously described (Marani et al., 2002). H. sapiens Bik and
its murine homologue (Biklk) were tested to analyze possible
species specific differences.
All clones cotransformed with pGBT9-A179L and pATC2-
BH3-only proteins, except those containing pATC2-Bid or
pATC2-Noxa, were able to grow to form blue-stained colonies
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and adenine. These results suggest that, as other apoptosis
suppressors which are members of Bcl-2 family, A179L
mediates inhibition through heterodimerization with BH3-
only proteins. However, A179L failed to associate with murine
complete Bid and human Noxa proteins. This result confirms
previous data obtained for porcine Bid, indicating that A179L
interacts only with active forms of Bid protein. Interestingly,
this viral gene failed to associate with Noxa suggesting that
A179L is not involved in the apoptosis pathway mediated by
this BH3-only protein.
BH3-only proteins are not the only targets described for viral
Bcl-2 homologues. Interactions with the core cellular proapop-
totic machinery, represented by Bax and Bak have been
identified for adenoviruses and herpesviruses among others
(Cuconati and White, 2002). Thus, to determine if the
mechanisms responsible for A179L mediated inhibition of
apoptosis were related with the core cellular proapoptotic
machinery, yeast two hybrid assays were performed using Bax
and Bak as preys. As indicated in Table 1, A179L was found to
interact with these two proteins.
To characterize the specificity of the A179L interactions, the
ability of other ASFV proteins to interact with these Bcl-2
propapoptotic members was also determined. ASFV p30
(Afonso et al., 1992), p54 (Rodriguez et al., 1994) and MyD
(Rivera et al., 2007) were chosen since these are major viral
proteins upon infection. None of these three virus proteins were
able to interact with Bcl-2 propapoptotic members in the yeast
two hybrid assays.
These results indicated that A179L selectively interacts with
functionally related Bcl-2 family members to inhibit apoptosis.
Hence, mechanisms underlying this A179L inhibition seem to
be related to heterodimerization with both the core apoptotic
machinery and its upstream regulators, the BH3-only proteins.
To confirm the interactions between A179L and the Bcl-2
proapoptotic proteins, previously identified by yeast two hybrid
assays, we tested most of these interactions in vitro using
recombinant proteins. A recombinant vaccinia virus expressing
A179L protein fused to glutathione S-transferase (GST–
A179L) was constructed. Several Bcl-2 proapoptotic proteinsFig. 5. A179L interaction with BimS, BimL, BimEL, Bad, Bmf, Bik and Biklk but
tagged BimS, BimL, BimEL, Bad, Bmf, Bik, Biklk or Noxa were incubated with equ
After extensive washing, proteins bound to beads were resolved by SDS-PAGE and i
shown to the left of the gel. Bands were quantified by densitometry using TINA softwa
is shown below.were expressed in Escherichia coli as fusion proteins with
polyhistidine tag (His–BH3-only proteins). Expression levels of
His–BH3-only proteins in E.coli were assessed by Western blot
(data not shown). Equal amounts, as judged by Coomassie blue
staining, of recombinant GST–A179L and GST were immobi-
lized on glutathione-sepharose beads and incubated with
bacterial cell extracts containing the His–BH3-only proteins.
After extensive washing, bound proteins to the G-Sepharose
beads were separated by SDS-PAGE and visualized by Western
blotting with a monoclonal antibody recognizing the His-tag.
A179L interacted with BimS, BimL, BimEL, Bad, Bmf, Bik
and Biklk. An interaction between A179L and Noxa was not
detected, confirming previous results obtained in yeast two
hybrid assay. An estimation of the percentages of BH3-only
proteins interacting with A179L and relative to BimS is shown
in Fig. 5. The control experiments showed that GST alone did
not interact with the Bcl-2 proapoptotic proteins analyzed.
Discussion
Apoptosis represents an important innate cellular mechanism
for curtailing virus infection, and many viruses have in turn,
developed strategies for inhibiting or delaying this cellular
response (Benedict et al., 2002). This represents a mechanism
used by the host immune system and the infected host cell itself
as part of the antiviral response but often contributes to
pathogenesis (Barber, 2001; Hardwick, 2001). For a successful
replication, viruses must modulate apoptotic pathways to extend
the lifespan of their host cell and encode homologues of
antiapoptotic Bcl-2 proteins to this end (Hardwick and Bellows,
2003). A179L is one of those viral Bcl-2 homologues that
protect cell from programmed cell death (Brun et al., 1996).
Various viral Bcl-2 homologues have been demonstrated to
interact with the core cellular proapoptotic machinery for
inhibition, but it was also proposed that these virus genes may
target BH3-only proteins, perhaps to secure a broad spectrum of
apoptosis inhibition to the infected cell. Recently, vaccinia virus
N1 protein, a novel Bcl-2-like antiapoptotic protein, has been
shown to interact with Bid, Bad and Bax (Cooray et al., 2007).
Alternatively, it may be so critically important to blocknot with Noxa, by GST-pull down assays. Bacterial cell lysates containing His-
al amounts of GST (a) or GST–A179L (b) attached to glutathione matrix beads.
nmunoblotted for anti His. The positions in Kilodaltons of protein standards are
re package (Raytest) and the percentage of protein in each lane, relative to BimS,
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redundant inhibitory mechanisms to ensure survival of the
infected cell. The first indication that the adenovirus Bcl-2 E1B
19K protein functions similarly to cellular Bcl-2 emerged when
a yeast two-hybrid screening using E1B 19K as bait, identified
Bax and Bak as interacting proteins (Farrow et al., 1995; Han
et al., 1996a,b). Nevertheless, searches in databases do not
reveal homology between adenovirus E1B 19K and Bcl-2. On
this basis, E1B 19K is referred to as a “functional homologue”
of Bcl-2 and the three dimensional structure revealed a folded
structure similar to Bcl-2 (Polster et al., 2004). Some other viral
Bcl-2 homologues share low amino acid sequence similarity
with cellular Bcl-2 such as murine γ-herpes virus 68 (γHV68)
M11 protein (Wang et al., 1999). Viral Bcl-2 homologues
sharing the four homology domains BH1–BH4 include human
herpes virus 8 Bcl-2 (Cheng et al., 1997), fowl poxvirus
(FPV039) (Banadyga et al., 2007) and ASFV A179L (Neilan
et al., 1993). The last one, lacking a putative membrane-
spanning region (Afonso et al., 1996).
Although the role of most of these viral Bcl-2 homologues in
infection have been gradually emerging (Cuconati and White,
2002), the biology of Bcl-2 homologue encoded by African
swine fever virus is poorly understood. This is related in part to
the complex genetic manipulation of this virus and the lack of
convenient cell culture system and/or animal models (Hardwick
and Bellows, 2003). In this work, using a porcine macrophage
cDNA library, by yeast two-hybrid screening with the A179L
protein as bait, we identified a truncated form of porcine Bid as
the first cellular interacting protein characterized. It is known
that after death receptors activation, the BH3-only Bid protein is
proteolysed by caspase 8 (Li et al., 1998), whereas Bid is
proteolysed by granzyme B during granule-mediated cytotoxic
T lymphocyte cell killing (Heibein et al., 2000). These post-
transductional modifications are necessary for function and then
truncated products are translocated to the mitochondria where
they promote the exit of cytochrome c (Fleischer et al., 2003).
We have described S. scrofa Bid and its truncated forms
encoding sequences, and according to the reported data for
human Bid only these truncated forms resulted proapoptotic.
Putative cleavage sites for caspase 8 and granzyme B were
found in the porcine Bid sequence that would generate two
carboxy-terminal fragments of 15 kDa (tBid-p15) and 13 kDa
(tBid-p13), similarly to human Bid. According to previous
results (Fleischer et al., 2003; Zha et al., 2000) we have shown
that only truncated Bid forms caused an efficient Bid-mediated
cell death, demostrating that a viral Bcl-2 is able to prevent this
process. Moreover, Bid is constitutively phosporylated and
must be dephosphorylated for inducing apoptosis. Several
residues of Bid are phosphorylation targets for casein kinases I
and II, being then insensitive to caspase 8 cleavage (Desagher et
al., 2001). Similarly to previously described Bid proteins, serine
residues present at porcine Bid protein also suggests a similar
regulation by phosphorylation status.
An intriguing fact was to find that full length Bid failed to
interact with A179L, given that the BH3 region is present in the
linear sequence of this protein. The solution structure of the Bid
protein was determined using NMR spectroscopy (Chou et al.,1999; McDonnell et al., 1999). The structure of full-length Bid
in solution consists of eight α-helices arranged with two central
somewhat more hydrophobic helices forming the core of the
molecule. The third helix, which contains the BH3 domain, is
connected to the first two helices by a long flexible loop, which
includes the caspase-8 cleavage site. After caspase cleavage, the
activated fragment, tBid, lacks the first helix, the small
additional helix, and part of the unstructured loop. Since the
first α-helix of Bid has hydrophobic interactions with the BH3
region in the native protein, removal of this helix would expose
a large hydrophobic surface on the BH3 helix, making it
accessible for binding by other Bcl-2 family members (Gong
et al., 2004; Petros et al., 2004).
Bid is the first molecule likely to be involved in A179L
pathway since we showed that, in transfected cells, A179L is
able to prevent Bid-induced apoptosis. This result indicates that
ASFV possibly inhibits the death receptor apoptosis pathway
downstream of caspase 8 or granzyme B activation which would
cleave Bid in its active forms and suggests then that one possible
function of A179L could be to prevent death of the infected cell
due to signaling by death cytokines. There are several examples
of inhibition of death receptor signaling by vBcl-2 proteins. The
BHRF1 and Balf1 proteins of EBV are capable of inhibiting
TNF-α and FasL induced cell death (Foghsgaard and Jaattela,
1997; Marshall et al., 1999). The M11 protein of γHV68 can
inhibit TNF-α and FasL induced cell death (Wang et al., 1999)
and the vBcl-2 of herpes virus saimiri (HVS) blocks Fas
signalling in a cell-type dependent manner (Derfuss et al., 1998;
Feng et al., 2004). Those examples indicate how crucial is for
infected cells to escape the attack of cytokine signaling triggered
by cytotoxic T cells. The presence of redundant antiapoptotic
functions in many viral genomes makes unclear what is the
overall contribution of vBcl-2 proteins in the inhibition of
cytokine death signaling during infection.
Interestingly, A179L is also capable of interacting with Bax
and Bak proapoptotic proteins and with most of the BH3-only
proteins described. This suggests that A179L protein acts as a
receptor for theBH3 domain of proapoptoticBcl-2 family proteins
and is able to antagonize their function. In doing this, the ASFV
Bcl-2 homologue is predicted to function by similar biochemical
mechanisms to cellular Bcl-2 (cBcl-2), namely by interacting with
other family members, and by either promoting or antagonizing
the function of its binding partner (Gross et al., 1999a). These
protein–protein interactions rely on the BH3 domain of one
protein, interacting with the hydrophobic cleft created by BH1–
BH3 domains of cBcl-2 (Sattler et al., 1997). This may explain
why BH1 domainmutations in ASFVBcl-2 homologue eliminate
its proapoptotic activity (Revilla et al., 1997).
Thus, cellular and viral Bcl-2 and perhaps other viral
antiapoptotic proteins could act both by inhibiting Bak/Bax and
by sequestering BH3-only death molecules. However, the
physiological context of these activities still remains to be
determined. It has been postulated that a possible preference of
viral Bcl-2 homologues for Bak and Bax versus BH3-only
proteins may vary their regulation and expression in different
cell types (Cuconati and White, 2002). As Polster et al. suggest
(Polster et al., 2004), it is difficult to conclude that vBcl-2
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than their upstream BH3 activators, since the majority of the
studies to date have been focused on Bax and Bak and rarely
covered an extensive study of vBcl-2 interactions with the
different BH3-death agonist molecules. Data presented in this
work for ASFV, suggest a relevant role for BH3-only molecules
as A179L targets. An interesting finding is that full length Bid
and Noxa have been the only exceptions which did not interact
with A179L. This differential targeting of BH3-only proteins
has been reported for the cellular prosurvival Bcl-2 family
members similarly, and Noxa also presented a more restrictive
binding (Chen et al., 2005). Noxa is highly specific for the
antiapoptotic Bcl-2 family members Mcl-1 and Bfl-1/A1 being
relevant for a fine tuning of survival/cell death pathways with
potential therapeutic applications.
In conclusion, we have shown the direct interaction of ASVF
A179L with the active forms of porcine Bid protein (tBid-p15
and p13) and that A179L was able to suppress mitochondrial
apoptotic signaling pathway initiated by these active Bid
proteins. We have also found A179L interactions with several
Bcl-2 family proapoptotic members, suggesting a pivotal role
for this virus Bcl-2 homologue in the regulation of apoptosis
during virus infection. These results indicate that ASFVA179L
protein could block apoptosis through interaction with specific
Bcl-2 proapoptotic proteins. As a consequence, the abrogation
of death receptor signaling through Bid could allow the infected
cell to escape immune surveillance by rendering the cell
resistant to the action of TNF-α, for instance. But as with most
DNAviruses, the activity of A179L during infection is only part
of a multilayered response to apoptosis induction from the
different antiapoptotic ASFV genes that apparently act to block
a wide spectrum of molecules and at different levels of distinct
apoptotic pathways (Hernaez et al., 2004b). Future work will be
directed to the elucidation of the role of the many ASFV
interactions with cell death related proteins and their relevance
along infection.
Materials and methods
Cell culture, viruses and transfection
Vero, BSC-1 and CV-1 cell lines were obtained from the
American Type Culture Collection (ATCC). Cells were
cultured in Dulbecco's modified Eagle's medium supplemen-
ted with 5% calf fetal serum, 100 IU/ml penicillin, and 100 μg/
ml streptomycin.
BA71V is the prototype ASFV strain used in our laboratory
and represents a high cell-passage number strain. Preparation of
viral stocks, titrations, and infection experiments were carried
out in Vero cells as previously described (Enjuanes et al., 1976;
Hernaez et al., 2004a,b). Viral DNAs preps were extracted from
infected Vero cells. Vaccinia virus vRB12 was made available
by R. Blasco. Vaccinia virus infections were performed with 2%
FBS in BSC-1 cells.
Vero cells grown to 40–50% confluence in 6-well culture
dishes were transfected using FUGENE6 (Roche) and 2 μgDNA/
106 (ratio 1:6), following manufacturer's recommendations.RNA isolation, RT-PCR and DNA RACE-PCR
Total RNA was isolated using Trizol reagent (Invitrogen).
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
amplification was carried out using Reverse Transcription System
(Promega) according to the protocol recommended by manufac-
ture. To obtain the sequence information for porcine Bid, we
applied the method of Rapid Amplification of cDNA Ends
(RACE) PCR (SMART™ RACE cDNA Amplification Kit,
Clontech) following the manufacture's directions. RACE-PCR
was carried on using SMART primer (Clontech) and a specific
primer based on the 5′ end of porcine Bid protein: 5′-TCAGT-
CCATCTCACTTTGGACTAAG-3′.
Vectors
Mammalian expression vectors
Plasmids expressing Bid, tBid-p13 or tBid-p15 were
generated by RACE-PCR amplification of porcine macrophage
total RNA to incorporate restriction sites (Supplementary table),
followed by ligation of the amplified cDNA fragments with
pCMV–myc plasmid (Clontech). The A179L gene was
amplified by PCR from purified BA71V DNA, using
oligonucleotides containing restrictions sites (supplementary
table), and subcloned into pCMV–HA vector (Clontech).
Yeast expression vectors
Full length cDNAs encoding A179L, p54, p30 and MyD
ASFV proteins were isolated from purified BA71V DNA and
cloned into the pGBT9 vector (Clontech). Bax (GenBank
accession no AY217036) and Bak (GenBank accession no
NM_001188) cDNA were obtained by RT-PCR from human
PBLs total RNA. Full length porcine Bid protein and its truncated
forms were cloned into the pATC2 vector (Clontech). DNAs
corresponding to BH3-only proteins were obtained from pEFFEE
plasmids, kindly provided by Drs. Huang and P. Bouillet
(Melbourne, Australia). The PCR products of Bcl-2 proapototic
members were digested and cloned into the BamHI/EcoRI sites of
pATC2 vector except for pATC2-Bax vector in which SmaI/
EcoRI sited were used. Primers used for plasmid generation are
listed in the supplementary table. All these constructs were
sequenced to ensure that no errors were introduced.
Pull down assays vectors
Plasmid pRBgA179L used for the construction of a
recombinant vaccinia virus expressing GST gene fused to the N
terminus of the A179L protein was obtained by sequential
cloning. The coding sequence of the A179L gene was amplified
by PCR, using the genome of BA71V as template and
oligonucleotides A179B (5′-AATATAGGGATCCGCTATG-
GAGGG-3′) (BamHI site underlined) andA179X (5′-GTAAAA-
TCCTGCGCTCGAGCTATATC-3′) (XhoI site underlined). The
PCR product was digested with BamHI and XhoI and inserted
into BamHI/XhoI digested pGEX4T3 (Amersham Pharmacia
Biotech) to generate pGEX-A179L.
The fusion gene GST–A179L was amplified by PCR from
plasmid pGEX–A179L with oligonucleotides GSTNhe (5'-
570 I. Galindo et al. / Virology 375 (2008) 561–572CACACAGGCTAGCGTATTCATGTCC-3') (NheI site under-
lined) and 179Hin (5'-GTCAGTCACGAAGCTTCCGC-
TCGA-3') (HindIII site underlined). The PCR product was
cut with NheI and HindIII and inserted into NheI/HindIII
digested pRB21 plasmid (Blasco and Moss, 1995) to generate
pRB21g–A179L.
The coding sequences of the BH3 only proteins were
amplified by PCR using the corresponding pATC2–BH3 only
proteins vectors as templates and the oligonucleotides in
supplementary table. The PCR products were digested and
cloned into the NdeI/XhoI sites of Pet-19b vector (Novagen)
fused to the C-terminus of the His-tag.
Construction of a vaccinia recombinant virus
Vaccinia recombinant virus was isolated following infection/
transfection experiments. CV-1 cells were infected with vRB12
at 0.05 PFU per cell and transfected 1 h later with pRBg-A179L
plasmid by use of Fugene6 transfection reagent following the
manufacturer's recommendations. Recombinant virus
(VVgA179L) was isolated from progeny virus by rounds of
plaque purification on BSC-1 cells by selecting large virus
plaques following protocols described previously (Blasco and
Moss, 1995).
Immunofluorescence
Vero cells seeded in 24-well chamber slides were transfected
with pCMV–myc and/or pCMV–HA constructions previously
described. At 24 h post transfection, cells were fixed with
acetone: methanol 1:1 for 2 min at −20°C. Mouse monoclonal
antibodies anti-myc-FITC (Babco) and anti-HA-Alexa 594
(Babco) were used at 1:25 dilution and 1:300 dilution,
respectively. Mitochondrial staining was carried out using a
potential-sensitive dye, chlorometil rosamine (CMXRos, Mole-
cular Probes) and nuclei were stained with Hoechst 33258
(Sigma). Caspase 3 activation was determined using C8487
rabbit polyclonal antibody (Sigma) which exclusively recog-
nizes the active form of caspase 3. After washing, coverslips
were finally mounted on glass plates and cells were observed by
confocal laser scanning microscopy in a Radiance 2100
MRC1024 (Bio-Rad) mounted on a Nikon Eclipse 300 micro-
scope. Stadistical analysis of colocalization was performed
using Lasersharp Processing 3.2 program (Bio-Rad).
Immunoprecipitation
Twenty four hours post-transfection, Vero cells expressing
pCMVtBid-p13–myc or pCMV–A179L–HAwere lysed using
non denaturing lysis buffer (50 mM Tris–HCl, pH 7.4, 300 mM
NaCl, 5 mM EDTA, 0.1% Triton X-100) and a protease
inhibitor cocktail (Roche), at 4°C. Cells were scraped, clarified
by centrifugation and supernatants were mixed. Previously,
Protein-A Sepharose (GE, Healthcare) was conjugated with
anti-HA antibody (Babco) or irrelevant rabbit serum as negative
control, for 16 h at 4°C. Supernatants were incubated with
conjugated beads for 4 h at 4°C and gently washed with nondenaturing lysis buffer. Bound proteins were eluted by boiling
in SDS sample buffer and resolved on a 10% SDS-PAGE gel.
Proteins were transferred onto a polyvinylidene difluoride
membrane and probed with monoclonal anti-myc (Clontech)
and anti-HA (Babco) antibodies. Proteins were detected using
rabbit anti IgG-HRP (Bio-rad) as secondary antibody.
Yeast two hybrid assays
For the yeast two-hybrid system, the plasmids pGBT9 and
pATC2 (Clontech) were used as sources of the GAL-4 DNA-
binding domain and GAL-4 transcriptional activation domain,
respectively. All materials used for the analysis were derived
from MATCHMAKER GAL-4 Two-Hybrid System (Clon-
tech). Yeast cells were grown on YPD (1% yeast extract, 2%
peptone, 2% dextrose, 2% agar for plates) or in synthetic
minimal medium (0.143% yeast nitrogen base, the appropriate
auxotrophic supplements) containing 2% of dextrose. Y190
strain carrying His3 and lacZ as reporter genes was transformed
with appropriate plasmids by the lithium acetate method (Gietz
and Woods, 2006). The transformants were selected on the
appropriate synthetic medium (SD/-Trp/-Leu/-His) and tested
by colon-lift filter assay β-galactosidase activity with 5-bromo-
4-chloro-3-indolyl β-D-galactopyranoside as substrate.
Pull down assays
For preparation of GST, and His-BH3 only proteins E. coli
strain BL21(DE3) cells, transformed with bacterial expression
vectors pGEX-4T3 and Pet-19b–BH3-only proteins, respec-
tively, were grown in LB medium supplemented with 50 µg/ml
ampicillin to an OD600 nm of 0.4 to 0.6 at 37 °C. Subsequently,
isopropyl-ß-D-thiogalactopyranoside (IPTG) was added to the
cell culture at a final concentration of 1 mM, and incubation
continued for an additional 4 h. Cells were harvested by
centrifugation, suspended in 5 ml of lysis buffer (phosphate-
buffered saline [PBS], 1% Triton X-100), and sonicated on ice.
For preparation of GST–A179L, BSC1 cells were infected with
VVgA179L virus at five PFU per cell. At 24 h postinfection, the
cells were scraped and suspended in lysis buffer, sonicated on
ice and spun down by centrifugation.
GST–A179L and GST proteins were purified by mixing
with glutathione-Sepharose 4B beads (GE, Healthcare) for 2 h
at 4 °C. Beads were washed with PBS. For the GST-based
interaction assay, equal amounts of GST–A179L or GST,
attached to glutathione matrix beads were incubated over-night
at 4 °C in a tube rotator with bacterial cell lysate, containing
expressed His-tagged BH3-only proteins, in binding buffer
(50 mM HEPES, pH 7.5, 50 mM NaCl, 0.1% NP-40 with
protease inhibitor mixture (Roche Molecular Biochemical).
Beads were extensively washed four times with binding buffer.
The glutathione-Sepharose beads immunoprecipitates were
resuspended in denaturant buffer, boiled for 5 min at 95 °C,
resolved by SDS-PAGE, blotted onto nitrocellulose membranes
and probed with mouse monoclonal anti-6×His (catalog no.
8916-1; Clontech) before detection by enhanced chemilumines-
cence (ECL kit; Amersham).
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